Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study

Overview of attention for article published in Molecular Autism, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users
patent: 1 patent

f1000: 1 research highlight platform

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Patents Research highlights Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

USE OF C188-9, VENETOCLAX, AND BUMETANIDE IN DRUG FOR FIBROTIC DISEASES

Application WO-2022027953-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.